Compare PLSE & EXPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | EXPO |
|---|---|---|
| Founded | 2014 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.2B |
| IPO Year | 2015 | 1996 |
| Metric | PLSE | EXPO |
|---|---|---|
| Price | $48.43 | $71.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $22.00 | ★ $88.00 |
| AVG Volume (30 Days) | 386.7K | ★ 400.8K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.19 |
| Revenue | N/A | ★ $582,014,000.00 |
| Revenue This Year | $840.00 | $12.75 |
| Revenue Next Year | $287.54 | $8.50 |
| P/E Ratio | ★ N/A | $59.79 |
| Revenue Growth | N/A | ★ 4.21 |
| 52 Week Low | $12.56 | $51.91 |
| 52 Week High | $50.90 | $81.95 |
| Indicator | PLSE | EXPO |
|---|---|---|
| Relative Strength Index (RSI) | 65.48 | 65.25 |
| Support Level | $24.27 | $69.27 |
| Resistance Level | N/A | $75.97 |
| Average True Range (ATR) | 2.87 | 1.85 |
| MACD | -0.26 | 0.08 |
| Stochastic Oscillator | 62.63 | 87.28 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.